Cleared Abbreviated

K072259 - OPHTHALMOSCOPE F-10

K072259 is the FDA 510(k) clearance for OPHTHALMOSCOPE F-10 by Nidek Co., Ltd.. It is a Class 2 Ophthalmic device (product code MYC) cleared through the Abbreviated 510(k) pathway after a 266-day FDA review.

K072259 · Nidek Co., Ltd. · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2008
Decision
266d
Days
Class 2
Risk

K072259 is an FDA 510(k) clearance for the OPHTHALMOSCOPE F-10. Classified as Ophthalmoscope, Laser, Scanning (product code MYC), Class II - Special Controls.

Submitted by Nidek Co., Ltd. (Marietta, US). The FDA issued a Cleared decision on May 6, 2008 after a review of 266 days - an extended review cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.1570 - the FDA ophthalmic device framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Nidek Co., Ltd. devices

Submission Details

510(k) Number K072259 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 14, 2007
Decision Date May 06, 2008
Days to Decision 266 days
Submission Type Abbreviated
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
156d slower than avg
Panel avg: 110d · This submission: 266d
Pathway characteristics
Standards-based clearance path.

Device Classification

Product Code MYC Ophthalmoscope, Laser, Scanning
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.1570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.